|
1
|
Joazeiro CA, Wing SS, Huang H, Leverson
JD, Hunter T and Liu YC: The tyrosine kinase negative regulator
c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
Science. 286:309–312. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brophy TM, Raab M, Daxecker H, Culligan
KG, Lehmann I, Chubb AJ, Treumann A and Moran N: RN181, a novel
ubiquitin E3 ligase that interacts with the KVGFFKR motif of
platelet integrin alpha(IIb)beta3. Biochem Biophys Res Commun.
369:1088–1093. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang S, Huang X, Li Y, Lao H, Zhang Y,
Dong H, Xu W, Li JL and Li M: RN181 suppresses hepatocellular
carcinoma growth by inhibition of the ERK/MAPK pathway. Hepatology.
53:1932–1942. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lange R, Christoph A, Thiesen HJ, Vopper
G, Johnson KR, Lemaire L, Plomann M, Cremer H, Barthels D and
Heinlein UA: Developmentally regulated mouse gene NK10 encodes a
zinc finger repressor protein with differential DNA-binding
domains. DNA Cell Biol. 14:971–981. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wong JM, Mafune K, Yow H, Rivers EN,
Ravikumar TS, Steele GD Jr and Chen LB: Ubiquitin-ribosomal protein
S27a gene overexpressed in human colorectal carcinoma is an early
growth response gene. Cancer Res. 53:1916–1920. 1993.PubMed/NCBI
|
|
6
|
Ganger DR, Hamilton PD, Klos DJ, Jakate S,
McChesney L and Fernandez-Pol JA: Differential expression of
metallopanstimulin/S27 ribosomal protein in hepatic regeneration
and neoplasia. Cancer Detect Prev. 25:231–236. 2001.PubMed/NCBI
|
|
7
|
Fatima G, Mathan G and Kumar V: The HBx
protein of hepatitis B virus regulates the expression,
intracellular distribution and functions of ribosomal protein S27a.
J Gen Virol. 93:706–715. 2012. View Article : Google Scholar
|
|
8
|
Wu ML, Layne MD and Yet SF: Heme
oxygenase-1 in environmental toxin-induced lung disease. Toxicol
Mech Methods. 22:323–329. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Caballero F, Meiss R, Gimenez A, Batlle A
and Vazquez E: Immunohistochemical analysis of heme oxygenase-1 in
preneoplastic and neoplastic lesions during chemical
hepatocarcinogenesis. Int J Exp Pathol. 85:213–222. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zou C, Zhang H, Li Q, Xiao H, Yu L, Ke S,
Zhou L, Liu W, Wang W, Huang H, et al: Heme oxygenase-1: a
molecular brake on hepatocellular carcinoma cell migration.
Carcinogenesis. 32:1840–1848. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin PH, Chiang MT and Chau LY:
Ubiquitin-proteasome system mediates heme oxygenase-1 degradation
through endoplasmic reticulum-associated degradation pathway.
Biochim Biophys Acta. 1783:1826–1834. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Coyle P, Philcox JC, Carey LC and Rofe AM:
Metallothionein: the multipurpose protein. Cell Mol Life Sci.
59:627–647. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tao X, Zheng JM, Xu AM, Chen XF and Zhang
SH: Downregulated expression of metallothionein and its
clinicopathological significance in hepatocellular carcinoma.
Hepatol Res. 37:820–827. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mao J, Yu H, Wang C, Sun L, Jiang W, Zhang
P, Xiao Q, Han D, Saiyin H, Zhu J, et al: Metallothionein MT1M is a
tumor suppressor of human hepatocellular carcinomas.
Carcinogenesis. 33:2568–2577. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pan Y, Huang J, Xing R, Yin X, Cui J, Li
W, Yu J and Lu Y: Metallothionein 2A inhibits NF-kappaB pathway
activation and predicts clinical outcome segregated with TNM stage
in gastric cancer patients following radical resection. J Transl
Med. 11:1732013. View Article : Google Scholar
|
|
16
|
Habel N, Hamidouche Z, Girault I,
Patiño-García A, Lecanda F, Marie PJ and Fromigué O: Zinc
chelation: a metallothionein 2A's mechanism of action involved in
osteosarcoma cell death and chemotherapy resistance. Cell Death
Dis. 4:e8742013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bao B, Prasad AS, Beck FW and Sarkar FH:
Zinc upregulates NF-kappaB activation via phosphorylation of
IkappaB in HUT-78 (Th0) cells. FEBS Lett. 581:4507–4511. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tian Y, Ding W, Wang Y, Ji T, Sun S, Mo Q,
Chen P, Fang Y, Liu J, Wang B, et al: Ubiquitin B in cervical
cancer: critical for the maintenance of cancer stem-like cell
characters. PLoS One. 8:e844572013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cacciapuoti F: Role of
ubiquitin-proteasome system (UPS) in left ventricular hypertrophy
(LVH). Am J Cardiovasc Dis. 4:1–5. 2014.PubMed/NCBI
|
|
20
|
Powell SR, Herrmann J, Lerman A, Patterson
C and Wang X: The ubiquitin-proteasome system and cardiovascular
disease. Prog Mol Biol Transl Sci. 109:295–346. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schlossarek S and Carrier L: The
ubiquitin-proteasome system in cardiomyopathies. Curr Opin Cardiol.
26:190–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Suh KS, Tanaka T, Sarojini S, Nightingale
G, Gharbaran R, Pecora A and Goy A: The role of the ubiquitin
proteasome system in lymphoma. Crit Rev Oncol Hematol. 87:306–322.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fukasawa H: The role of the
ubiquitin-proteasome system in kidney diseases. Clin Exp Nephrol.
16:507–517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomas SS and Mitch WE: Mechanisms
stimulating muscle wasting in chronic kidney disease: the roles of
the ubiquitin-proteasome system and myostatin. Clin Exp Nephrol.
17:174–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rogers N, Paine S, Bedford L and Layfield
R: Review: the ubiquitin-proteasome system: contributions to cell
death or survival in neurodegeneration. Neuropathol Appl Neurobiol.
36:113–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ying Z, Wang H and Wang G: The ubiquitin
proteasome system as a potential target for the treatment of
neurodegenerative diseases. Curr Pharm Des. 19:3305–3314. 2013.
View Article : Google Scholar
|
|
27
|
Dawson SP: Hepatocellular carcinoma and
the ubiquitin-proteasome system. Biochim Biophys Acta.
1782:775–784. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grande E, Earl J, Fuentes R and Carrato A:
New targeted approaches against the ubiquitin-proteasome system in
gastrointestinal malignancies. Expert Rev Anticancer Ther.
12:457–467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Voutsadakis IA: The ubiquitin-proteasome
system in colorectal cancer. Biochim Biophys Acta. 1782:800–808.
2008. View Article : Google Scholar : PubMed/NCBI
|
